Diego A. Díaz García(@diegoadiazg) 's Twitter Profile Photo

Molecular pathways, resistance mechanisms and targeted interventions in NSCLC.

Potential therapies to overcome the challenges of drug resistance.

DOI doi.org/10.1186/s43556…

Molecular pathways, resistance mechanisms and targeted interventions in NSCLC. 

Potential therapies to overcome the challenges of drug resistance. 

DOI doi.org/10.1186/s43556…

#nsclc #targetedtherapies #precisiononcology #lcsm
account_circle
OncoViews(@OncoViews) 's Twitter Profile Photo

We had a wonderful first discussion for on ❗️

Here's an important message from Oliver Gautschi & Stephen V Liu, MD on testing.

Don't worry if you missed it as we've got you covered! Full video is now freely available on oncoviews.com 📺🎥

account_circle
Sumera Ilyas(@SumeraIlyasMD) 's Twitter Profile Photo

Great MTE session w/Dr. Andrew Zhu. We touched on everything from liquid biopsies, recent exciting FDA approvals for , to combo ICI/chemo, ICI/locoregional, ICI/targeted, cell based therapies for . Having fun while learning - can’t ask for more!

Great MTE session w/Dr. Andrew Zhu. We touched on everything from liquid biopsies, recent exciting FDA approvals for #targetedtherapies, to combo ICI/chemo, ICI/locoregional, ICI/targeted, cell based therapies for #CCA. Having fun while learning - can’t ask for more!#LiverMtg21
account_circle
Lorey Smith(@Smith_Lorey) 's Twitter Profile Photo

Excited to share our paper published last night in Nature Communications! We show translational regulation of promotes resistance to in and that inhibiting the RNA binding kinase UHMK1 can block this process. Check it out 👉🏻 rdcu.be/cHZu7

Excited to share our paper published last night in @NatureComms! We show translational regulation of #metabolism promotes resistance to #targetedtherapies in #melanoma and that inhibiting the RNA binding kinase UHMK1 can block this process. Check it out 👉🏻 rdcu.be/cHZu7
account_circle
HemaSphere Journal (IF = 9.1)(@Hemasphere_EHA) 's Twitter Profile Photo

New review: challenges + perspectives for therapeutic targeting of , discussing based on molecular insight, combi tx, novel single agent investigations, & specific patient subset needs 👉bit.ly/393XCmL

New review: challenges + perspectives for therapeutic targeting of #MyeloproliferativeNeoplasms, discussing #TargetedTherapies based on molecular insight, combi #JAK2inhibitor tx, novel single agent investigations, & specific patient subset needs 👉bit.ly/393XCmL
#mpnsm
account_circle